Pembrolizumab in Hepatocellular Carcinoma
Pembrolizumab in Hepatocellular Carcinoma
Active, not recruiting · NCT03419481 · Registry updated 2026-03-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab in Hepatocellular Carcinoma | hepatocellular carcinoma | Active, not recruiting | Phase 2 | 2026-03-04 | NCT03419481 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CCTU | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Clinical Oncology, Prince of Wales Hospital | Hong Kong | Hong Kong | 16 |